LONDON, 13 November 2018 – Consilium Strategic Communications (“Consilium”), a global leader in strategic healthcare communications, together with Berenberg, Cooley and Westwicke Partners, will host their sixth Annual Healthcare Conference today in London.
This annual event brings together individuals in senior roles from across the international healthcare sector and investment community to provide new perspectives on the key topics impacting the industry alongside high-quality networking.
With close to 300 delegates expected from companies across Europe and the US, as well as representatives of the funding and investment community and business development specialists, this year promises to be our best-attended and most dynamic event yet.
The conference will take place at the De Vere Connaught Rooms, 61-65 Great Queen Street, London WC2B 5DA. The event will run from 12pm, starting with lunch, and will conclude at 5pm followed by networking drinks.
Conference programme:
| 12:00pm – 1:00pm | Lunch and Networking |
| 1:00pm – 1.15pm | Welcome and Introductions |
| 1:15pm – 1:30pm | Keynote Speech by Tom Lynch |
| 1:30pm – 2:15pm | Venture Forth |
| Newer and more diverse forms of venture capital are coming into the sector, changing the rules of engagement for companies seeking funding and increasingly becoming involved in IPOs. How should companies take advantage of this new influx of venture money? And what are the implications for the broader investment model. | |
| Speakers:Naveed Siddiqi, Andera PartnersVictor Christou, Cambridge Innovation CapitalEva-Lotta Allan, C4X DiscoveryTom Burt, Sofinnova PartnersMike Townend, IP Group | |
| 2:15pm – 3:00pm | Advanced Therapies |
| With ground-breaking medicines such as gene and cell passing some of the final hurdles to approval and on the market, how is the infrastructure of the biopharma industry, companies, regulators and governments alike, responding to the pace of challenge, how will it be priced and reimbursed? | |
| Speakers:Chris Hollowood, SynconaJohn Brown, Cell and Gene Therapy CatapultAnnalisa Jenkins, Cell MedicaJames Noble, AdaptimmuneBharatt Chowrira, PureTech Health | |
| 3:00pm – 3.30pm | Break |
| 3.30pm – 4:15pm | Artificial Intelligence |
| Artificial Intelligence has moved from blue-sky thinking to the next big thing. How will AI shape treatment and policy for healthcare? | |
| Speakers:Lord (Paul) Drayson, Sensyne HealthShane de Bhrun-Smith, Canaccord Fund ManagementJean-Pol Detiffe, OncoDNAClive Dix, C4X Discovery | |
| 4.15pm – 5:00pm | Fireside chatMichael Hayden, Former President of Global R&D and Chief Scientific Officer at Teva, Killam Professor of Medical Genetics at the University of British Columbia and Canada Research Chair in Human Genetics and Molecular Medicine, speaking to Mike Ward, Chief Content Officer, Informa Pharma Insights |
| 5:00pm – 6:30pm | Networking Drinks |
“This has been another positive year for the industry and the pace of change has remained as fast as ever – with Consilium thriving at the heart of it and continuing its rapid international growth in its sixth year since establishment.
Mary-Jane Elliott
Managing Partner of Consilium Strategic Communications
“Our conference has become an annual fixture and a great opportunity to take stock of these developments and think about the year ahead. With an afternoon of high-quality discussion from key decision-makers and an evening of good networking we, along with our partners Berenberg, Cooley and Westwicke Partners, look forward to welcoming you to the event.”
Mary-Jane Elliott
Managing Partner of Consilium Strategic Communications
Follow the event on Twitter at: #CSCHealth18
